RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BALDARI S
Collezione AOU San Luigi di Orbassano

Items : 5

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors. in JAMA network open / JAMA Netw Open. 2022 Feb 1;5(2):e220290. doi: 10.1001/jamanetworkopen.2022.0290.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Modica R; Andreasi V; Spada F; Severi S; Bracigliano A; Ambrosio MR; Zanata I; Puliafito I; Lamberti G; Cingarlini S; Rocca PA; Pignata SA; Rinzivillo M; Persano I; Versari A; Bongiovanni A; Lastoria S; Maccauro M; Seregni E; Di Maio M; Porcu L; Giacomelli L; Ricci C; Corti F; Perfetti V; Cirillo F; Grimaldi F; Cives M; Bajetta E; et alii...

Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet). in Journal of endocrinological investigation / J Endocrinol Invest. 2021 May;44(5):989-994. doi: 10.1007/s40618-020-01393-4. Epub 2020 Aug 16.

2021
AOU San Luigi di Orbassano

Panzuto F; Maccauro M; Campana D; Faggiano A; Massironi S; Pusceddu S; Spada F; Ferone D; Modica R; Grana CM; Ferolla P; Rinzivillo M; Badalamenti G; Zatelli MC; Gelsomino F; De Carlo E; Bartolomei M; Brizzi MP; Cingarlini S; Versari A; Fanciulli G; Arvat E; Merola E; Cives M; Tafuto S; Baldari S; Falconi M; Panzuto F; Maccauro M; et alii...

Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients. in Future oncology (London, England) / Future Oncol. 2021 Mar;17(7):807-815. doi: 10.2217/fon-2020-0391. Epub 2021 Jan 29.

2021
ASL Asti
AOU San Luigi di Orbassano

Salgarello M; Borsatti E; Pignata S; Zichi C; Filice A; Murabito A; Biasco E; Fanti S; Palermo A; Alongi P; Alongi F; Bortolus R; Facchini G; Baldari S; Tucci M; Pinto C; Costa RP; Sbrana A; Monari F; Caffo O; Frantellizzi V; Spada M; Cortesi E; Vincentis G;

Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without (223)Ra. in Cancer biotherapy & radiopharmaceuticals / Cancer Biother Radiopharm. 2021 Jun;36(5):391-396. doi: 10.1089/cbr.2020.4442. Epub 2021 Mar 25.

2021
ASL Asti
AOU San Luigi di Orbassano

Spada M; Salgarello M; Borsatti E; Pignata S; Zichi C; Masini C; Morabito A; Fanti S; Sbrana A; Donner D; Alongi P; Alongi F; Bortolus R; Facchini G; Tucci M; Baldari S; Pinto C; Costa RP; Galli L; Monari F; Caffo O; Frantellizzi V; De Giorgi U; Lo Re G; Cortesi E; De Vincentis G;

Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2633-2638. doi: 10.1007/s00259-020-04796-w. Epub 2020 Ap

2020
AOU San Luigi di Orbassano

Caffo O; Frantellizzi V; Tucci M; Galli L; Monari F; Baldari S; Masini C; Bortolus R; Facchini G; Alongi P; Agostini S; Zichi C; Biasco E; Fanti S; Pignata S; Filice A; Borsatti E; Rossetti S; Spada M; Cortesi E; De Vincentis G;